From April 1, 2022 to June 30, 2022, the company has repurchased 1,470,456 shares, representing 1.26% for $200 million. With this, the company has completed the repurchase of 85,243,240 shares, representing 58.99% for $7,357.56 million under the buyback announced on October 20, 2010.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,636 GBX | -0.91% | +1.58% | +12.81% |
Apr. 24 | CureVac Begins Early Stage Portion of Investigational Vaccine Trial | MT |
Apr. 24 | Global markets live: Heineken, AT&T Hasbro, Visa, Boeing... |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.81% | 83.92B | |
+25.61% | 672B | |
+25.87% | 570B | |
-5.24% | 360B | |
+16.49% | 321B | |
+8.28% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.